PE-backed Unbounce acquires LeadsRx

Unbounce, which is backed by Crest Rock Partners, has acquired Portland, Oregon-based LeadsRx, a marketing attribution SaaS platform.

Unbounce, which is backed by Crest Rock Partners, has acquired Portland, Oregon-based LeadsRx, a marketing attribution SaaS platform. No financial terms were disclosed.


Denver, CO – January 20, 2022 – Crest Rock Partners, a Denver-based private equity firm investing in lower middle market software, technology, services, and manufacturing companies, enthusiastically announces its portfolio company, Unbounce, the leading Conversion Intelligence software platform, has acquired LeadsRx, a marketing attribution SaaS platform that provides brand and agency marketers with impartial, actionable attribution data and insights. This acquisition further expands Unbounce’s Conversion Intelligence platform, bringing the power of marketing attribution to its customers.

Founded in 2015 in Portland, Oregon, LeadsRx helps marketers measure and understand the value of each customer touchpoint across digital, radio, TV, podcasts, streaming services, and other advertising channels, allowing them to better optimize their conversion paths, ad spend and ROI.

“LeadsRx’s marketing attribution and analytics software is a force multiplier for marketers,” said Steve Johnson, Partner & Co-founder of Crest Rock. “Bringing these capabilities into Unbounce’s Conversion Intelligence platform significantly enhances Unbounce’s offering and the value they deliver to their customers.”

Since its inception, LeadsRx has helped marketers optimize billions of dollars in marketing spend, collect anonymous customer data from 2.5 billion customer touchpoints, and help them make faster and more informed decisions. Today, LeadsRx serves more than 5,000 global and local brands and agencies ranging from iHeartMedia and Casper to Cumulus Media, Diray Media and Rakuten Advertising.

“Attribution is one of the most painful parts of marketing — validating your costs and ROI to your CEO, clients and investors is harder than ever as competition and new marketing channels continue to grow at a rapid pace. LeadsRx solves these pain points for marketers by showing them which channels are performing and which aren’t,” said Tamara Grominsky, Chief Strategy Officer of Unbounce. “By combining LeadsRx’s wealth of new data with our Conversion Intelligence platform, we have the opportunity to deliver conversion value to marketers across a wider spectrum of the marketing funnel. We’re thrilled to welcome LeadsRx to the Unbounce team as we continue our journey of bringing conversion intelligence solutions to marketers around the world.”

“Unbounce and LeadsRx share a vision for the future of marketing that machines and marketers can work better together to produce the best results possible,” added AJ Brown, CEO and co-founder of LeadsRx. “We’re bringing together some of the most creative and inventive engineers, marketing and customer services professionals — I’m excited for what the future holds and the innovative products we will be able to offer companies and agencies around the world.”

Alkali Partners, an independent investment bank, facilitated this transaction as the financial advisor to LeadsRx.

About Unbounce
Unbounce is a Conversion Intelligence platform that pairs a marketer’s own know-how and expertise with machine learning to effortlessly increase sales and conversions. From pre-optimized landing pages to compelling copy creation, to campaign optimization with the flip of a switch, Unbounce is helping marketers grow smarter and faster. Founded in Vancouver, BC, Unbounce is a people-first business, one of Canada’s most admired corporate cultures and has powered over 1.5 billion conversions worldwide. To learn more about the company, visit, and connect on LinkedIn and Twitter.